EMAIL THIS PAGE TO A FRIEND

Anticancer Research

TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitro.


PMID 25202072

Abstract

We're sorry this abstract is currently not available.